MAQI2 Anticoagulation Toolkit vs avoMD
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MAQI2 Anticoagulation Toolkit
This mobile application offers healthcare professionals a current and user-friendly guide for safer and more effective management of patients on anticoagulation therapy. Developed by leading experts, it incorporates the latest research and guidelines.
- Up-to-date resource
- Easy-to-use interface
- Patient management
- Latest guidelines
- Expert-developed content
Read full descriptionHide full description
This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
avoMD
This app offers interactive guidance for clinicians evaluating adult patients for noncardiac surgery. It incorporates co-morbidities, medications, and medical calculators based on established guidelines and literature reviews. Enhance your learning with evidence-based references and detailed explanations.
- Interactive patient evaluation
- Preoperative risk assessment
- Medical calculators (RCRI, MICA, etc.)
- Evidence-based references
- Literature review integration
- Co-morbidity and medication tracking
Read full descriptionHide full description
avoMD: Preoperative Eval provides quick, interactive, and educational guidance to help clinicians evaluate and prepare adult patients for noncardiac surgery. The app is based primarily on the 2014 ACC/AHA Perioperative Guidelines but also includes additional comments from reviews of the literature up to September 2020. It was developed in conjunction with Dr. Steven Cohn, a leading expert in Perioperative Medicine. The app incorporates co-morbidities, patient medications, interactive medical calculators (like RCRI, MICA, ACS-SRC, DASI), and other information and tools to help clinicians assess the risk of surgery. avoMD provides links to the evidence-based references and best practices, as well as more detailed explanations on the recommendations, so that clinicians can enhance their learning experience. Dr. Steven Cohn is currently Professor Emeritus at the University of Miami Miller School of Medicine, having served as the Medical Director of the UHealth Preoperative Assessment Center (UPAC) and the Medical Consultation Services at the University of Miami Hospital and Jackson Memorial Hospital. He was the former Chief of the Division of General Internal Medicine at SUNY Downstate and the Director of the Preoperative Medical Consultation Clinic and Medical Consultation Service at Kings County Hospital Center. avoMD transforms clinical guidelines and content into interactive, next-gen apps. The team is led by physicians and informaticians from Columbia, Yale, and Harvard, while current partners include leading academic medical centers, urgent care providers and a growing number of residency programs and medical schools across the US. The company won the 2020 pitch competitions at Columbia Engineering and Penn Medicine and recently joined StartUp Health and 500 Startups. Interested in customizing avoMD for your department/institution? Contact info@avomd.io for more information.
Screenshots
Verdict
The clearest difference is in-app purchases: MAQI2 Anticoagulation Toolkit at none against avoMD's 4. avoMD's advantage is update cadence (every 9 days vs every 4 months) and rating (5.0 vs 4.8). On price, review sentiment, ratings volume and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. avoMD sells 4 in-app purchases, starting at $9.99 per year. MAQI2 Anticoagulation Toolkit asks for nothing beyond the download.
avoMD holds the better App Store score, 5.0 against 4.8. Both are backed by a comparable volume of ratings — 8 and 15 respectively. Written reviews split almost evenly too, at 100% and 100% positive.
MAQI2 Anticoagulation Toolkit ships an update every 4 months, avoMD every 9 days. The most recent releases landed on October 30, 2026 and October 24, 2026 respectively.
| Parameter | MAQI2 Anticoagulation Toolkit | avoMD |
|---|---|---|
| Price | Free | Free |
| Rating | 4.8 (8 ratings) | 5.0 (15 ratings) — better |
| Positive reviews | 100.0% of reviews | 100.0% of reviews |
| Number of ratings | 8 | 15 — better |
| Update frequency | Every 4 months | Every 9 days — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 15 | 13.0 — better |
| Further details — not scored | ||
| Size | 6 MB | 20 MB |
| Age rating | 17+ | 12+ |
| Developer | The University of Michigan | avoMD, Inc |
Customer experience
MAQI2 Anticoagulation Toolkit
avoMD
In-app purchases
MAQI2 Anticoagulation Toolkit
No in-app purchases
avoMD
- 1 Year Assitance 1 month trial1 Month trial$9.991 Year
- 1 year assistance 3 month free3 Months trial$9.991 Year
- Institutional Plan$14.991 Year
Show 1 moreShow fewer
- 1 year assistance 6 month free6 Months trial$19.991 Year







